Position in SCYX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$235,937
+$28,938 QoQ
Shares Held
57,970
+105.4% QoQ
Ownership
0.583%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 39 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCYX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026VANGUARD FIDUCIARY TRUST CO holds $1,050,112,943 across 54 Drug Manufacturers - Specialty & Generic names. SCYX ranks #42 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,365,836 | $170,008,974 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
268,477 | $145,468,892 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
647,763 | $109,173,976 | |
| 4 | VTRS |
Viatris Inc
|
6,543,475 | $103,910,383 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,164,376 | $77,875,293 | |
| 6 | ALKS |
Alkermes plc.
|
1,177,945 | $61,724,318 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
1,522,249 | $52,776,372 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
466,076 | $51,706,471 |
All Filings in SCYX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $235,937 | 57,970 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $206,999 | 225,736 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||